Drug Study - Losartan Potassium

Posted by: Admin

To receive automatic updates of Nursing News, Nursing Care Plans, Case Studies and the much awaited November 2008 Nursing Board Exam Result: click Subscribe to NursingCrib.com by Email or via RSS. If you have other topics to discuss, make a post on our Nursing Crib Forum. Thanks for visiting and enjoy your stay!

Cozaar

Action:

Angiotensin II receptor (type AT₁) antagonist acts as a potent vasoconstrictor and primary vasoactive hormone of the renin–angiotensin–aldosterone system.

Classifications:

cardiovascular agent; angiotensin ii receptor antagonist; antihypertensive

Indication:

Hypertension

Download

_____________________________________________________________________________________________

• Drug Study - Catopril Capoten Action: Lowers blood pressure by specific inhibition of the angiotensin-converting enzyme (ACE). This interrupts conversion sequences initiated by renin that lead to formation of angiotensin II, a potent endogenous vasoconstrictor. ACE inhibition alters hemodynamics without compensatory reflex tachycardia or changes in cardiac output (except in patients with CHF). Peripheral vascular resistance is lowered by vasodilation.
• Drug Study - Clonidine Hydrochloride Catapres, Catapres-TTS, Dixaril , Duraclon Action: Centrally acting antiadrenergic derivative. Stimulates alpha2-adrenergic receptors in CNS to inhibit sympathetic vasomotor centers. Central actions reduce plasma concentrations of norepinephrine. It decreases systolic and diastolic BP and heart rate. Orthostatic effects tend to be mild and occur infrequently. Also inhibits renin release from kidneys.. Classifications: cardiovascular agent; central-acting antihypertensive; analgesic Indication: Step 2 drug
• Drug Study - Ranitidine by: ishi21, RN Zantac, Zantac EFFERdose, Zantac GELdose, Zantac-75 Action: Potent anti-ulcer drug that competitively and reversibly inhibits histamine action at H2-receptor sites on parietal cells, thus blocking gastric acid secretion. Indirectly reduces pepsin secretion but appears to have minimal effect on fasting and postprandial serum gastrin concentrations or secretion of gastric intrinsic factor or mucus Classifications: GASTROINTESTINAL AGENT; ANTISECRETORY
• Drug Study - Furosemide Fumide , Furomide , Lasix, Luramide Action: Rapid-acting potent sulfonamide “loop” diuretic and antihypertensive with pharmacologic effects and uses almost identical to those of ethacrynic acid. Exact mode of action not clearly defined; decreases renal vascular resistance and may increase renal blood flow. Classification: ELECTROLYTIC AND WATER BALANCE AGENT; LOOP DIURETIC Indication: Treatment of edema associated with CHF, cirrhosis of liver,
• Drug Study - Dopamine Hydrochloride by: ishi21, RN Dopastat, Intropin, Revimine Action: Naturally occurring neurotransmitter and immediate precursor of norepinephrine. Major cardiovascular effects produced by direct action on alpha- and beta-adrenergic receptors and on specific dopaminergic receptors in mesenteric and renal vascular beds. Classifications: AUTONOMIC NERVOUS SYSTEM AGENT; ALPHA- AND BETA-ADRENERGIC AGONIST (SYMPATHOMIMETIC) Indication: To correct hemodynamic imbalance in shock syndrome due to MI (cardiogenic shock),